Clinical Outcomes of Liver Transplantation for Hbv-Related Hepatocellular Carcinoma: Data From the Nih Hbv Olt Study Academic Article uri icon

abstract

  • Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) is an indication for orthotopic liver transplantation (OLT) in patients with tumor stage within the United Network for Organ Sharing criteria. The number of patients listed for HBV-related HCC is increasing, while the number of patients listed for HBV-related cirrhosis is declining presumptively because of the availability of more effective oral nucleos(t)ide analogues. This study presents the final, long-term outcome of patients transplanted for HBV-related HCC in the National Institutes of Health (NIH) HBV OLT Study Group.

publication date

  • 2011-03-01